Drug intelligence / Profile preview

clotiapine

Development stage
Unknown
Lead developer
Wander
Modality
Small Molecules
Administration
Oral, Intramuscular, Intravenous
01

Overview

Clotiapine is an atypical antipsychotic belonging to the dibenzothiazepine chemical class, originally developed by Wander AG (later part of Novartis). It is primarily utilized in the treatment of schizophrenia and acute psychotic disorders, particularly in cases that are resistant to other treatments or require rapid tranquilization. The drug's pharmacological profile is characterized by its broad-spectrum antagonism of multiple G-protein coupled receptors, including potent activity at dopamine D2 and serotonin 5-HT2A receptors. It also exhibits significant affinity for histamine H1, alpha-1 adrenergic, and muscarinic acetylcholine receptors, which contributes to its pronounced sedative and anxiolytic effects. Clotiapine is available in both oral and parenteral formulations, making it a versatile option in emergency psychiatry for managing acute agitation and severe psychosis.

Brand names
EntuminEntumineEtumine
Other names
clothiapine
02

Targets

DRD4 (Dopamine D4 Receptor)HRH1 (Histamine H1 Receptor)HTR2C (5-hydroxytryptamine 2C receptor)mAChR (Muscarinic acetylcholine receptors)DRD1 (Dopamine D1 Receptor)ADRA1A (α1A)DRD2 (Dopamine D2 Receptor)HTR2A (Serotonin receptor 5-HT2A)

Beyond the preview

Go deeper on clotiapine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clotiapine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call